Recent Updates
Recently added Catalysts
TMDX Negative Sentiment Score: 25/100

TransMedics Group, Inc. Announcement: If You Have Suffered Losses in TransMedics Group, Inc. (NASDAQ: TMDX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Key Takeaway: TransMedics Group, Inc. is under investigation following allegations of misleading business practices which impacted its stock value. On January 10, 2025, a scathing report by Scorpion Capital termed the company as one of the worst healthcare frauds encountered, based on its treatment of terminally ill patients. The stock price has fallen notably, losing over $8.50 in value in just a few days. The Rosen Law Firm is inviting affected investors to participate in a class action lawsuit aiming for compensation without upfront costs.

Market Sentiment Analysis

CONCERNS & RISKS

  • Allegations of materially misleading business information issued by TransMedics.
  • Scorpion Capital's report labels TransMedics as an extreme healthcare fraud.
  • Stock prices have significantly dropped after the report's release.

Full Press Release Details

NEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) --
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation on behalf of shareholders of TransMedics Group, Inc. (NASDAQ: TMDX) resulting from allegations that TransMedics may have issued materially misleading business information to the investing public.
SO WHAT: If you purchased TransMedics securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=22793 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.
WHAT IS THIS ABOUT: On January 10, 2025, Scorpion Capital issued a report about TransMedics. In this report, Scorpion Capital stated that in “20 years of shorting, TransMedics is the most extreme and grotesque healthcare fraud we have encountered, not only for its scale, but because it is predicated on the exploitation of the most vulnerable patients – the terminally ill, desperate for an organ. The ‘lucky’ patients who receive a diseased, damaged organ rejected by reputable surgeons and centers [. . .] are oblivious to the cesspool of perverse, secret incentives that steered the organ their way. [Corruption pervades] every aspect of the business model.”
On this news, TransMedics stock fell $3.74 per share, or 5.15%, to close at $68.81 on January 10, 2025. On January 13, 2025, TransMedics stock fell a further $4.76 per share, or 6.9%, to close at $64.05.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
Toll Free: (866) 767-3653

Tags

Frequently Asked Questions

What is the reason for the investigation of TransMedics?

The Rosen Law Firm is investigating TransMedics for potentially misleading business information.

How can I join the class action against TransMedics?

To join, visit the Rosen Law Firm's website or contact Phillip Kim at 866-767-3653.

What caused TransMedics stock to drop recently?

The stock dropped following a report from Scorpion Capital alleging healthcare fraud.

Why choose the Rosen Law Firm for legal representation?

The firm has a strong track record in securities class actions and significant investor recoveries.

Is there any cost to join the class action?

Yes, shareholders can join without any out-of-pocket fees through a contingency agreement.

Last updated: Jan 15, 2025